Potential application of functional porous TiO2 nanoparticles in light-controlled drug release and targeted drug delivery
Source abstract
Abstract
Novel multifunctional porous titanium dioxide (TiO2) nanoparticles modified with polyethylenimine (PEI) were developed to explore the feasibility of exploiting the photocatalytic property of titanium dioxide to achieve ultraviolet (UV) light triggered drug release. Additionally, in order to further realize targeting delivery, folic acid, which chemically conjugated to the surface of the functionalized multifunctional porous TiO2 nanoparticles through amide linkage with free amine groups of PEI, was used as a cancer-targeting agent to effectively promote cancer-cell-specific uptake through receptor-mediated endocytosis. And a typical poorly water-soluble anti-cancer drug, paclitaxel, was encapsulated in multifunctional porous TiO2 nanoparticles. The PEI on the surface of multifunctional porous TiO2 nanoparticles could effectively block the channel to prevent premature drug release, thus providing enough circulation time to target cancer cells. Following UV light radiation, PEI molecules on the surface were cut off by the free radicals (OH˙ and O2-) that TiO2 produced, and then the drug loaded in the carrier was released rapidly into the cytoplasm. Importantly, the amount of drug released from multifunctional porous TiO2 nanoparticles can be regulated by the UV-light radiation time to further control the anti-cancer effect. This multifunctional porous TiO2 nanoparticle exhibits a combination of stimuli-triggered drug release and cancer cell targeting. The authors believe that the present study will provide important information for the use of porous TiO2 nanomaterials in light-controlled drug release and targeted therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery · TiO2 Photocatalysis and Solar Cells
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Targeted nanoparticles for cancer therapy10.1016/S1748-0132(07)70083-X ↗
2. Population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer10.1016/j.clbc.2011.10.005 ↗
3. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
4. Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy10.1016/j.nantod.2010.05.001 ↗
5. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes10.1016/j.biomaterials.2013.02.066 ↗
6. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cell10.1016/j.ejpb.2013.07.016 ↗
7. Peptides in cancer nanomedicine: drug carrier targeting ligands and protease substrates10.1016/j.jconrel.2011.10.023 ↗
8. LHRH-conjugated lytic peptides directly target prostate cancer cells10.1016/j.bcp.2010.09.015 ↗
9. Monoclonal antibody therapy of cancer10.1038/nbt1137 ↗
10. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates10.1016/j.addr.2004.01.011 ↗
11. Guided delivery of polymer therapeutics using plasmonic photothermal therapy10.1016/j.nantod.2012.04.002 ↗
12. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects10.1016/j.nantod.2012.08.005 ↗
13. Nanostructured titanium oxynitride porous thin films as efficient visible-active photocatalysts10.1002/adfm.200700396 ↗
14. Nanostructured materials for electrochemical energy conversion and storage devices10.1002/adma.200800627 ↗
15. Characteristics of silica-coated TiO2 and its UV absorption for sunscreen cosmetic applications10.1002/sia.2313 ↗
16. Self-organized TiO2 nanotube array sensor for the determination of chemical oxygen demand10.1002/adma.200701619 ↗
17. Photokilling cancer cells using highly cell-specific antibody–TiO2 bioconjugates and electroporation
18. Ti based biomaterials, the ultimate choice for orthopaedic implants10.1016/j.pmatsci.2008.06.004 ↗
19. Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO210.1016/j.biomaterials.2010.03.021 ↗
20. Distance dependence of the photocatalytic efficiency of TiO2 revealed by in situ ellipsometry10.1021/ja303170h ↗
21. Amphiphilic TiO2 Nanotube arrays: an actively controllable drug delivery system10.1021/ja810130h ↗
22. Titanium dioxide nanomaterials: synthesis, properties, modifications, and applications10.1021/cr0500535 ↗
23. Mesoporous titania: from synthesis to application10.1016/j.nantod.2012.06.012 ↗
24. Nanostructured pure anatase titania tubes replicated from electrospun polymer fiber templates by atomic layer deposition10.1021/cm703398b ↗
25. Enhancing the photocatalytic activity of TiO2 co-doping of grapheme-Fe3+ ions for formaldehyde removal10.1016/j.jenvman.2013.04.029 ↗
26. Synthesis, characterization and application of bismuth and boron Co-doped TiO2: a visible light active photocatalyst10.1016/j.cej.2012.11.080 ↗
27. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan10.1016/j.jconrel.2010.04.029 ↗
28. Development of an amorphous mesoporous TiO2 nanosphere as a novel carrier for poorly water-soluble drugs: Effect of different crystal forms of TiO2 carriers on drug loading and release behaviors10.1016/j.micromeso.2011.12.013 ↗
29. Targeting of porous hybrid silica nanoparticles to cancer cells10.1021/nn800781r ↗
30. Receptor-targeted gene delivery viafolate-conjugated polyethylenimin
31. Poly(ethylenimine) and its role in gene delivery10.1016/S0168-3659(99)00090-5 ↗
32. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis10.1002/jgm.696 ↗
33. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles10.1016/j.ijpharm.2010.10.038 ↗
34. Tumor delivery of macromolecular drugs based on the EPR effect10.1016/j.addr.2010.03.011 ↗
35. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting10.1016/S0065-2571(00)00013-3 ↗